Seppo Ylae-Herttuala

Title: Seppo Ylae-Herttuala: Innovator in Angiogenesis

Introduction

Seppo Ylae-Herttuala is a prominent inventor based in Kuopio, Finland. He has made significant contributions to the field of angiogenesis, particularly through his innovative patent that focuses on stimulating angiogenic activity. His work has implications for various medical applications, particularly in the treatment of ischemic diseases.

Latest Patents

Ylae-Herttuala holds a patent for "In vivo stimulation of angiogenic activity." This patent describes a method where angiogenesis is stimulated by introducing two replication-deficient adenovirus vectors to the endothelial cells or nearby cells of an organism. The first vector encodes VEGF-B or a fragment thereof, while the second vector encodes VEGF-A or VEGF-C, or their respective fragments. This innovative approach has the potential to enhance blood vessel formation, which is crucial for healing and recovery in various medical conditions. He has 1 patent to his name.

Career Highlights

Throughout his career, Ylae-Herttuala has been recognized for his groundbreaking research and contributions to the field of vascular biology. His work has paved the way for new therapeutic strategies aimed at improving blood flow and tissue regeneration. His expertise in gene therapy and molecular biology has made him a key figure in the scientific community.

Collaborations

Ylae-Herttuala has collaborated with notable scientists, including Berndt Enholm and Didier Branellec. These collaborations have further enriched his research and expanded the impact of his work in the field of angiogenesis.

Conclusion

Seppo Ylae-Herttuala is a distinguished inventor whose work in angiogenesis has the potential to transform medical treatments. His innovative approaches and collaborations highlight his commitment to advancing scientific knowledge and improving patient outcomes.